pimavanserin

The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Flag link:
Schizophrenia: Four major clinical trials to watch in 2023
Schizophrenia: Four major clinical trials to watch in 2023
Clinical Trials Arena
clinical trials
schizophrenia
Reviva
brilaroxazine
Newron
evenamide
Sunovion
ulotaront
Acadia Pharma
pimavanserin
Flag link:
5 FDA approval decisions to watch in the second quarter
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
FDA
Biogen
aducanumab
Acadia Pharmaceuticals
pimavanserin
AstraZeneca
vaccines
COVID-19
Sanofi
Avalglucosidase alfa
Pfizer
pneumococcal disease
Flag link:
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
CP Wire
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Parkinson's Disease Psychosis
Flag link:
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Flag link:
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Yahoo/Reuters
Acadia
Alzheimer's disease
pimavanserin
Flag link:
Acadia: Approval Likely For Parkinson's Disease Psychosis Drug
Acadia: Approval Likely For Parkinson's Disease Psychosis Drug
Seeking Alpha
Acadia
Parkinson's Disease Psychosis
pimavanserin
Flag link:
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
Yahoo/AP
FDA
Parkinson's Disease Psychosis
Acadia
advisory panels
pimavanserin
Flag link:
Acadia surges after nabbing 'breakthrough' title for late-stage Parkinson's drug
Acadia surges after nabbing 'breakthrough' title for late-stage Parkinson's drug
Fierce Biotech
Parkinson's Disease
Acadia
pimavanserin
Flag link:
Acadia On Track With Pimavanserin Development Program
Acadia On Track With Pimavanserin Development Program
Yahoo/Zacks.com
Acadia
pimavanserin
earnings
Parkinson's Disease Psychosis
Flag link:
Alzheimer's Needs Cures, Not Pyrrhic Victories
Alzheimer's Needs Cures, Not Pyrrhic Victories
Motley Fool
Alzheimer's disease
pimavanserin
Acadia
Sangamo BioSciences
Valeant Pharmaceuticals
Bexarotene
Merck
BACE inhibitors
AstraZeneca
solanezumab
Eli Lilly
Flag link:
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Yahoo/Benzinga
FDA
drug approvals
Acadia
Alexion
InterMune
Merrimack Pharmaceuticals
Soliris
pimavanserin
MM-398
Esbriet
Flag link:
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
Flag link:
3 Drugmakers to Watch in the New Year
3 Drugmakers to Watch in the New Year
Motley Fool
pimavanserin
Acadia
Zerenex
Keryx
Iclusig
Ariad Pharmaceuticals
Flag link:
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Parkinson's Disease
pimavanserin
Acadia
Duodopa
AbbVie
LCIG
AFQ056
Novartis
Flag link:
Acadia And Parkinson's Treatment Hopes
Acadia And Parkinson's Treatment Hopes
Seeking Alpha
Parkinson's Disease
Acadia
pimavanserin
Parkinson's Disease Psychosis
Flag link:
2 Companies Offering Hope In the Fight Against Parkinson’s Disease
2 Companies Offering Hope In the Fight Against Parkinson’s Disease
Wall St. Cheat Sheet
Parkinson's Disease
Acadia
International Stem Cell Corp
pimavanserin
parthenogenesis
Flag link:
Acadia Targets Pimavanserin NDA For Late 2014
Acadia Targets Pimavanserin NDA For Late 2014
Seeking Alpha
pimavanserin
Acadia
Flag link:
Expect Huge Upside to This Biotech Stock as It Approaches FDA Approval
Expect Huge Upside to This Biotech Stock as It Approaches FDA Approval
Motley Fool
FDA
AstraZeneca
Novartis
Acadia
pimavanserin
Flag link:
Acadia Gets Expedited FDA Review Path for Lead Drug
Acadia Gets Expedited FDA Review Path for Lead Drug
Bloomberg
Acadia
FDA
pimavanserin
Parkinson's Disease
Flag link:

Pages